almost significantp=0.0589
As reported before, also B cells were higher in ASCT+ patients (11.43 ± 11.0% vs 6.5 ± 6.6%, p<0.0001), with significant increase in CD19+/CD5- B cells (4.6± 4.8% vs 2.1± 2.8%, p<0.0001) and an almost significant increase of CD19+/CD5+ B cells (1.9 ± 3.1% vs 1.3 ± 2.3%, p=0.0589) ( Supplementary Figures 5C–E ).